Harbour Trust & Investment Management Co

Position in NVO — Novo Nordisk A S

CIK 2003557 MICHIGAN CITY, IN

Position in NVO

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,324,917

-$3,779 QoQ

Shares Held

27,637

-23.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#456

of 1,348 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

Harbour Trust & Investment Management Co holds $35,892,215 across 8 Drug Manufacturers - General names. NVO ranks #5 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	15,533	$18,630,747
2	JNJ	Johnson & Johnson	35,017	$8,893,267
3	ABBV	AbbVie Inc.	14,893	$3,747,674
4	AMGN	Amgen Inc	3,809	$1,379,314
5	NVO	Novo Nordisk A S This page	27,637	$1,324,917
6	NVS	Novartis AG	7,649	$1,198,751
7	GILD	Gilead Sciences, Inc.	3,450	$435,873
8	MRK	Merck & Co., Inc.	2,192	$281,672

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,324,917	27,637	-23.6%	Shares	Sole	2026-07-28
2026-03-31	$1,328,696	36,155	-8.9%	Shares	Sole	2026-04-28
2025-12-31	$2,019,732	39,696	-60.9%	Shares	Sole	2026-01-28
2025-09-30	$5,635,675	101,562	-4.4%	Shares	Sole	2025-10-28
2025-06-30	$7,331,786	106,227	-1.0%	Shares	Sole	2025-07-28
2025-03-31	$7,448,202	107,261	+26.1%	Shares	Sole	2025-04-28
2024-12-31	$7,317,376	85,066	-14.8%	Shares	Sole	2025-01-29
2024-09-30	$11,882,828	99,797	+4.7%	Shares	Sole	2024-10-23
2024-06-30	$13,610,686	95,353	+39.0%	Shares	Sole	2024-07-23
2024-03-31	$8,808,882	68,605	+16.3%	Shares	Sole	2024-04-22
2023-12-31	$6,104,687	59,011	—	Shares	Sole	2024-01-26
No filing history on record for this holder in this stock.